Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-22

Clinical Trial Update: Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage [NA]

View source ↗

Summary

This clinical trial update concerns the use of exenatide for hypothalamic obesity and diabetes mellitus, but no status or results are provided for the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Huashan Hospital | Conditions: Hypothalamic Obesity, Diabetes Mellitus | NA | Status: UNKNOWN